Ikarian Capital, LLC Biotechnology

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
VRTX
Vertex Pharmaceuticals Inc
CALL
$46.5 Million
100K
Q2 2022
Added 60.0%
VRTX
Vertex Pharmaceuticals Inc
PUT
$46.5 Million
100K
Q2 2022
Added 60.0%
JANX
Janux Therapeutics, Inc.
PUT
$16.6 Million
365K N/A
IMVT
Immunovant, Inc.
CALL
$13.8 Million
500K
Q1 2024
Added 18.65%
CLDX
Celldex Therapeutics, Inc.
PUT
$10.4 Million
306K
Q1 2023
Reduced 60.35%
CLDX
Celldex Therapeutics, Inc.
CALL
$10.4 Million
306K
Q1 2023
Reduced 60.35%
BGNE
Bei Gene, Ltd.
CALL
$6.69 Million
29.8K
Q3 2024
New holding
APLS
Apellis Pharmaceuticals, Inc.
PUT
$5.77 Million
200K
Q1 2024
Added 2.13%
AKRO
Akero Therapeutics, Inc.
PUT
$5.71 Million
199K
Q3 2023
New holding
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$4.99 Million
23.5K
Q4 2022
New holding
CAPR
Capricor Therapeutics, Inc.
PUT
$4.56 Million
300K
Q3 2024
New holding
CAPR
Capricor Therapeutics, Inc.
CALL
$4.56 Million
300K
Q3 2024
New holding
VRDN
Viridian Therapeutics, Inc.\De
CALL
$4.55 Million
200K
Q3 2024
New holding
APLS
Apellis Pharmaceuticals, Inc.
CALL
$4.33 Million
150K
Q1 2024
Added 2.13%
BDTX
Black Diamond Therapeutics, Inc.
PUT
$4.13 Million
950K
Q3 2023
Added 1.92%
BDTX
Black Diamond Therapeutics, Inc.
CALL
$3.04 Million
700K
Q3 2023
Added 1.92%
CYTK
Cytokinetics Inc
CALL
$2.76 Million
52.3K
Q2 2024
Added 17.22%
SANA
Sana Biotechnology, Inc.
CALL
$2.7 Million
650K N/A
SANA
Sana Biotechnology, Inc.
PUT
$2.7 Million
650K N/A
RCUS
Arcus Biosciences, Inc.
CALL
$1.74 Million
114K
Q3 2024
Added 413.1%
SRRK
Scholar Rock Holding Corp
CALL
$1.62 Million
202K
Q2 2024
Reduced 37.02%
SRRK
Scholar Rock Holding Corp
PUT
$1.62 Million
202K
Q2 2024
Reduced 37.02%
FULC
Fulcrum Therapeutics, Inc.
CALL
$1.51 Million
423K
Q3 2024
New holding
SWTX
Spring Works Therapeutics, Inc.
CALL
$1.4 Million
43.8K
Q3 2023
New holding
GALT
Galectin Therapeutics Inc
PUT
$1.38 Million
500K N/A
GALT
Galectin Therapeutics Inc
CALL
$1.38 Million
500K N/A
PYXS
Pyxis Oncology, Inc.
CALL
$1.32 Million
359K
Q3 2024
Reduced 42.41%
CRVS
Corvus Pharmaceuticals, Inc.
CALL
$1.15 Million
218K
Q2 2022
Closed
BMEA
Biomea Fusion, Inc.
PUT
$535,000
53K
Q2 2023
Added 30.76%
PRTA
Prothena Corp Public LTD CO
CALL
$197,000
11.8K
Q2 2021
Closed
PRTA
Prothena Corp Public LTD CO
PUT
$197,000
11.8K
Q2 2021
Closed
FULC
Fulcrum Therapeutics, Inc.
PUT
$81,000
22.8K
Q3 2024
New holding
Filter Shares Options
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email